Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept.
Identifieur interne : 000785 ( Main/Exploration ); précédent : 000784; suivant : 000786Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept.
Auteurs : Pierre-Marie Duret [Oman] ; Eden Sebbag [France] ; Auriane Mallick [France] ; Simon Gravier [France] ; Lionel Spielmann [France] ; Laurent Messer [France]Source :
- Annals of the rheumatic diseases [ 1468-2060 ] ; 2020.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen (MeSH), Antirhumatismaux (usage thérapeutique), Betacoronavirus (MeSH), Humains (MeSH), Infections à coronavirus (complications), Infections à coronavirus (traitement médicamenteux), Infections à coronavirus (virologie), Mâle (MeSH), Pandémies (MeSH), Pneumopathie virale (complications), Pneumopathie virale (traitement médicamenteux), Pneumopathie virale (virologie), Résultat thérapeutique (MeSH), Spondylarthrite (traitement médicamenteux), Spondylarthrite (virologie), Étanercept (usage thérapeutique).
- MESH :
- traitement médicamenteux : Infections à coronavirus, Pneumopathie virale, Spondylarthrite.
- usage thérapeutique : Antirhumatismaux, Infections à coronavirus, Pneumopathie virale, Étanercept.
- virologie : Infections à coronavirus, Pneumopathie virale, Spondylarthrite.
- Adulte d'âge moyen, Betacoronavirus, Humains, Mâle, Pandémies, Résultat thérapeutique.
English descriptors
- KwdEn :
- Antirheumatic Agents (therapeutic use), Betacoronavirus (MeSH), Coronavirus Infections (complications), Coronavirus Infections (drug therapy), Coronavirus Infections (virology), Etanercept (therapeutic use), Humans (MeSH), Male (MeSH), Middle Aged (MeSH), Pandemics (MeSH), Pneumonia, Viral (complications), Pneumonia, Viral (drug therapy), Pneumonia, Viral (virology), Spondylarthritis (drug therapy), Spondylarthritis (virology), Treatment Outcome (MeSH), Tumor Necrosis Factor Inhibitors (therapeutic use).
- MESH :
- chemical , therapeutic use : Antirheumatic Agents, Etanercept, Tumor Necrosis Factor Inhibitors.
- complications : Coronavirus Infections, Pneumonia, Viral.
- drug therapy : Coronavirus Infections, Pneumonia, Viral, Spondylarthritis.
- virology : Coronavirus Infections, Pneumonia, Viral, Spondylarthritis.
- Betacoronavirus, Humans, Male, Middle Aged, Pandemics, Treatment Outcome.
DOI: 10.1136/annrheumdis-2020-217362
PubMed: 32354772
PubMed Central: PMC7456545
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept.</title>
<author><name sortKey="Duret, Pierre Marie" sort="Duret, Pierre Marie" uniqKey="Duret P" first="Pierre-Marie" last="Duret">Pierre-Marie Duret</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Rheumatology, Hôpitaux Civils de Colmar, Colmar, Alsace, France pierremarie.duret@gmail.com.</nlm:affiliation>
<country wicri:rule="url">Oman</country>
<wicri:regionArea>Department of Rheumatology, Hôpitaux Civils de Colmar, Colmar, Alsace</wicri:regionArea>
<wicri:noRegion>Alsace</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Sebbag, Eden" sort="Sebbag, Eden" uniqKey="Sebbag E" first="Eden" last="Sebbag">Eden Sebbag</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Rheumatology-Centre National de Référence des Maladies Systémiques Rares Est Sud-Ouest (RESO), Hôpitaux Universitaires de Strasbourg, Strasbourg, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Rheumatology-Centre National de Référence des Maladies Systémiques Rares Est Sud-Ouest (RESO), Hôpitaux Universitaires de Strasbourg, Strasbourg</wicri:regionArea>
<placeName><region type="region">Grand Est</region>
<region type="old region">Alsace (région administrative)</region>
<settlement type="city">Strasbourg</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Mallick, Auriane" sort="Mallick, Auriane" uniqKey="Mallick A" first="Auriane" last="Mallick">Auriane Mallick</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Rheumatology, Hôpitaux Civils de Colmar, Colmar, Alsace, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Rheumatology, Hôpitaux Civils de Colmar, Colmar, Alsace</wicri:regionArea>
<wicri:noRegion>Alsace</wicri:noRegion>
<wicri:noRegion>Alsace</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gravier, Simon" sort="Gravier, Simon" uniqKey="Gravier S" first="Simon" last="Gravier">Simon Gravier</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Infectious Diseases, Hopitaux Civils de Colmar, Colmar, Alsace, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Infectious Diseases, Hopitaux Civils de Colmar, Colmar, Alsace</wicri:regionArea>
<wicri:noRegion>Alsace</wicri:noRegion>
<wicri:noRegion>Alsace</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Spielmann, Lionel" sort="Spielmann, Lionel" uniqKey="Spielmann L" first="Lionel" last="Spielmann">Lionel Spielmann</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Rheumatology, Hôpitaux Civils de Colmar, Colmar, Alsace, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Rheumatology, Hôpitaux Civils de Colmar, Colmar, Alsace</wicri:regionArea>
<wicri:noRegion>Alsace</wicri:noRegion>
<wicri:noRegion>Alsace</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Messer, Laurent" sort="Messer, Laurent" uniqKey="Messer L" first="Laurent" last="Messer">Laurent Messer</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Rheumatology, Hôpitaux Civils de Colmar, Colmar, Alsace, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Rheumatology, Hôpitaux Civils de Colmar, Colmar, Alsace</wicri:regionArea>
<wicri:noRegion>Alsace</wicri:noRegion>
<wicri:noRegion>Alsace</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32354772</idno>
<idno type="pmid">32354772</idno>
<idno type="doi">10.1136/annrheumdis-2020-217362</idno>
<idno type="pmc">PMC7456545</idno>
<idno type="wicri:Area/Main/Corpus">001509</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001509</idno>
<idno type="wicri:Area/Main/Curation">001509</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001509</idno>
<idno type="wicri:Area/Main/Exploration">001509</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept.</title>
<author><name sortKey="Duret, Pierre Marie" sort="Duret, Pierre Marie" uniqKey="Duret P" first="Pierre-Marie" last="Duret">Pierre-Marie Duret</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Rheumatology, Hôpitaux Civils de Colmar, Colmar, Alsace, France pierremarie.duret@gmail.com.</nlm:affiliation>
<country wicri:rule="url">Oman</country>
<wicri:regionArea>Department of Rheumatology, Hôpitaux Civils de Colmar, Colmar, Alsace</wicri:regionArea>
<wicri:noRegion>Alsace</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Sebbag, Eden" sort="Sebbag, Eden" uniqKey="Sebbag E" first="Eden" last="Sebbag">Eden Sebbag</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Rheumatology-Centre National de Référence des Maladies Systémiques Rares Est Sud-Ouest (RESO), Hôpitaux Universitaires de Strasbourg, Strasbourg, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Rheumatology-Centre National de Référence des Maladies Systémiques Rares Est Sud-Ouest (RESO), Hôpitaux Universitaires de Strasbourg, Strasbourg</wicri:regionArea>
<placeName><region type="region">Grand Est</region>
<region type="old region">Alsace (région administrative)</region>
<settlement type="city">Strasbourg</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Mallick, Auriane" sort="Mallick, Auriane" uniqKey="Mallick A" first="Auriane" last="Mallick">Auriane Mallick</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Rheumatology, Hôpitaux Civils de Colmar, Colmar, Alsace, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Rheumatology, Hôpitaux Civils de Colmar, Colmar, Alsace</wicri:regionArea>
<wicri:noRegion>Alsace</wicri:noRegion>
<wicri:noRegion>Alsace</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gravier, Simon" sort="Gravier, Simon" uniqKey="Gravier S" first="Simon" last="Gravier">Simon Gravier</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Infectious Diseases, Hopitaux Civils de Colmar, Colmar, Alsace, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Infectious Diseases, Hopitaux Civils de Colmar, Colmar, Alsace</wicri:regionArea>
<wicri:noRegion>Alsace</wicri:noRegion>
<wicri:noRegion>Alsace</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Spielmann, Lionel" sort="Spielmann, Lionel" uniqKey="Spielmann L" first="Lionel" last="Spielmann">Lionel Spielmann</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Rheumatology, Hôpitaux Civils de Colmar, Colmar, Alsace, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Rheumatology, Hôpitaux Civils de Colmar, Colmar, Alsace</wicri:regionArea>
<wicri:noRegion>Alsace</wicri:noRegion>
<wicri:noRegion>Alsace</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Messer, Laurent" sort="Messer, Laurent" uniqKey="Messer L" first="Laurent" last="Messer">Laurent Messer</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Rheumatology, Hôpitaux Civils de Colmar, Colmar, Alsace, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Rheumatology, Hôpitaux Civils de Colmar, Colmar, Alsace</wicri:regionArea>
<wicri:noRegion>Alsace</wicri:noRegion>
<wicri:noRegion>Alsace</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Annals of the rheumatic diseases</title>
<idno type="eISSN">1468-2060</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antirheumatic Agents (therapeutic use)</term>
<term>Betacoronavirus (MeSH)</term>
<term>Coronavirus Infections (complications)</term>
<term>Coronavirus Infections (drug therapy)</term>
<term>Coronavirus Infections (virology)</term>
<term>Etanercept (therapeutic use)</term>
<term>Humans (MeSH)</term>
<term>Male (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (complications)</term>
<term>Pneumonia, Viral (drug therapy)</term>
<term>Pneumonia, Viral (virology)</term>
<term>Spondylarthritis (drug therapy)</term>
<term>Spondylarthritis (virology)</term>
<term>Treatment Outcome (MeSH)</term>
<term>Tumor Necrosis Factor Inhibitors (therapeutic use)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen (MeSH)</term>
<term>Antirhumatismaux (usage thérapeutique)</term>
<term>Betacoronavirus (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Infections à coronavirus (complications)</term>
<term>Infections à coronavirus (traitement médicamenteux)</term>
<term>Infections à coronavirus (virologie)</term>
<term>Mâle (MeSH)</term>
<term>Pandémies (MeSH)</term>
<term>Pneumopathie virale (complications)</term>
<term>Pneumopathie virale (traitement médicamenteux)</term>
<term>Pneumopathie virale (virologie)</term>
<term>Résultat thérapeutique (MeSH)</term>
<term>Spondylarthrite (traitement médicamenteux)</term>
<term>Spondylarthrite (virologie)</term>
<term>Étanercept (usage thérapeutique)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antirheumatic Agents</term>
<term>Etanercept</term>
<term>Tumor Necrosis Factor Inhibitors</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
<term>Spondylarthritis</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
<term>Spondylarthrite</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antirhumatismaux</term>
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
<term>Étanercept</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
<term>Spondylarthrite</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
<term>Spondylarthritis</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Betacoronavirus</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Pandemics</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Betacoronavirus</term>
<term>Humains</term>
<term>Mâle</term>
<term>Pandémies</term>
<term>Résultat thérapeutique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32354772</PMID>
<DateCompleted><Year>2020</Year>
<Month>09</Month>
<Day>08</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>09</Month>
<Day>08</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-2060</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>79</Volume>
<Issue>9</Issue>
<PubDate><Year>2020</Year>
<Month>09</Month>
</PubDate>
</JournalIssue>
<Title>Annals of the rheumatic diseases</Title>
<ISOAbbreviation>Ann. Rheum. Dis.</ISOAbbreviation>
</Journal>
<ArticleTitle>Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept.</ArticleTitle>
<Pagination><MedlinePgn>1251-1252</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1136/annrheumdis-2020-217362</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Duret</LastName>
<ForeName>Pierre-Marie</ForeName>
<Initials>PM</Initials>
<Identifier Source="ORCID">0000-0003-1070-8830</Identifier>
<AffiliationInfo><Affiliation>Department of Rheumatology, Hôpitaux Civils de Colmar, Colmar, Alsace, France pierremarie.duret@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Sebbag</LastName>
<ForeName>Eden</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>Department of Rheumatology-Centre National de Référence des Maladies Systémiques Rares Est Sud-Ouest (RESO), Hôpitaux Universitaires de Strasbourg, Strasbourg, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Mallick</LastName>
<ForeName>Auriane</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Department of Rheumatology, Hôpitaux Civils de Colmar, Colmar, Alsace, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Gravier</LastName>
<ForeName>Simon</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Department of Infectious Diseases, Hopitaux Civils de Colmar, Colmar, Alsace, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Spielmann</LastName>
<ForeName>Lionel</ForeName>
<Initials>L</Initials>
<Identifier Source="ORCID">0000-0003-1057-6890</Identifier>
<AffiliationInfo><Affiliation>Department of Rheumatology, Hôpitaux Civils de Colmar, Colmar, Alsace, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Messer</LastName>
<ForeName>Laurent</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Department of Rheumatology, Hôpitaux Civils de Colmar, Colmar, Alsace, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>04</Month>
<Day>30</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Ann Rheum Dis</MedlineTA>
<NlmUniqueID>0372355</NlmUniqueID>
<ISSNLinking>0003-4967</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018501">Antirheumatic Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000079424">Tumor Necrosis Factor Inhibitors</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>OP401G7OJC</RegistryNumber>
<NameOfSubstance UI="D000068800">Etanercept</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName>
<SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName>
<SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D018501" MajorTopicYN="N">Antirheumatic Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="Y">Betacoronavirus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000068800" MajorTopicYN="N">Etanercept</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D025241" MajorTopicYN="N">Spondylarthritis</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000079424" MajorTopicYN="N">Tumor Necrosis Factor Inhibitors</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">antirheumatic agents</Keyword>
<Keyword MajorTopicYN="Y">arthritis, infectious</Keyword>
<Keyword MajorTopicYN="Y">biological therapy</Keyword>
<Keyword MajorTopicYN="Y">spondylitis, ankylosing</Keyword>
<Keyword MajorTopicYN="Y">tumour necrosis factor inhibitors</Keyword>
</KeywordList>
<CoiStatement>Competing interests: None declared.</CoiStatement>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>03</Month>
<Day>17</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2020</Year>
<Month>04</Month>
<Day>18</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>04</Month>
<Day>20</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>5</Month>
<Day>2</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>9</Month>
<Day>9</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>5</Month>
<Day>2</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32354772</ArticleId>
<ArticleId IdType="pii">annrheumdis-2020-217362</ArticleId>
<ArticleId IdType="doi">10.1136/annrheumdis-2020-217362</ArticleId>
<ArticleId IdType="pmc">PMC7456545</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>N Engl J Med. 1996 Jun 27;334(26):1697-702</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8637514</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Autoimmun Rev. 2020 May;19(5):102523</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32205186</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Mar 28;395(10229):1033-1034</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32192578</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Med Res Opin. 2004 Jan;20(1):39-40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14741070</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 May 2;395(10234):1407-1409</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32278362</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Rheumatol. 2020 Jun;16(6):293-294</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32242121</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>France</li>
<li>Oman</li>
</country>
<region><li>Alsace (région administrative)</li>
<li>Grand Est</li>
</region>
<settlement><li>Strasbourg</li>
</settlement>
</list>
<tree><country name="Oman"><noRegion><name sortKey="Duret, Pierre Marie" sort="Duret, Pierre Marie" uniqKey="Duret P" first="Pierre-Marie" last="Duret">Pierre-Marie Duret</name>
</noRegion>
</country>
<country name="France"><region name="Grand Est"><name sortKey="Sebbag, Eden" sort="Sebbag, Eden" uniqKey="Sebbag E" first="Eden" last="Sebbag">Eden Sebbag</name>
</region>
<name sortKey="Gravier, Simon" sort="Gravier, Simon" uniqKey="Gravier S" first="Simon" last="Gravier">Simon Gravier</name>
<name sortKey="Mallick, Auriane" sort="Mallick, Auriane" uniqKey="Mallick A" first="Auriane" last="Mallick">Auriane Mallick</name>
<name sortKey="Messer, Laurent" sort="Messer, Laurent" uniqKey="Messer L" first="Laurent" last="Messer">Laurent Messer</name>
<name sortKey="Spielmann, Lionel" sort="Spielmann, Lionel" uniqKey="Spielmann L" first="Lionel" last="Spielmann">Lionel Spielmann</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000785 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000785 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= CovidFranceV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:32354772 |texte= Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32354772" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a CovidFranceV1
This area was generated with Dilib version V0.6.37. |